(Q46164038)

20 December 2017

title

[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. (English)

1 reference

20 December 2017

author name string

Victoria S Warbey

1

1 reference

20 December 2017

Rosalie E Ferner

2

1 reference

20 December 2017

Joel T Dunn

3

1 reference

20 December 2017

Eduardo Calonje

4

1 reference

20 December 2017

Michael J O'Doherty

5

1 reference

20 December 2017

publication date

14 January 2009

1 reference

20 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

20 December 2017

volume

36

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

751-757

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-008-1038-0

exact match

0 references

cites work

CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-008-1038-0

A PET study of 18FDG uptake in soft tissue masses

21 January 2018

1 reference

12 December 2020

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

1 reference

12 December 2020

Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance.

1 reference

12 December 2020

[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study

1 reference

12 December 2020

Value of PET in the assessment of patients with neurofibromatosis type 1.

1 reference

12 December 2020

International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis.

1 reference

12 December 2020

Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.

1 reference

12 December 2020

Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system

1 reference

12 December 2020

Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours

1 reference

12 December 2020

Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors

1 reference

12 December 2020

Use of the CT component of PET-CT to improve PET-MR registration: demonstration in soft-tissue sarcoma.

1 reference

12 December 2020

Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours

1 reference

12 December 2020

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases

1 reference

12 December 2020

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective.

1 reference

12 December 2020

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity

1 reference

12 December 2020

10.1007/S00259-008-1038-0

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

19142634

1 reference

20 December 2017